Hims & Hers Q1 net loss $92.1M; revenue $608M (+4% YoY); raises FY2026 guidance to $2.8B-$3.0B

Hims & Hers Health, Inc.

2026-Q1 EPS reported -$0.40 vs consensus $0.04 ▼ miss (-1005.0%)

Revenue $608.1M (+4% YoY); net loss $92.1M vs net income $49.5M in Q1 2025.
Adjusted EBITDA $44.3M vs $91.1M; gross margin fell to 65% from 73%.
Subscribers 2.584M (+9% YoY); monthly revenue per subscriber $80 (-6%).
FY2026 revenue guidance raised to $2.8B–$3.0B; Adjusted EBITDA guidance $275M–$350M.
Proposed acquisition of Eucalyptus expected mid-2026; not included in guidance.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Hims & Hers Health, Inc. reported the first quarter ended March 31, 2026 results: revenue $608.1 million, net income $92.1 million. Guidance raised.

Period: the first quarter ended March 31, 2026
Revenue: $608.1 million
Net income: $92.1 million
Guidance: raised
Result: reported results

Exact text from the filing

Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results Revenue of approximately $608 million, up 4% year-over-year in Q1 2026

View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

Hims & Hers Health, Inc. filing history →

Source: SEC EDGAR

accession 0001773751-26-000074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.